Serum alkaline phosphatase levels in patients with Hodgkin's and non-Hodgkin's lymphoma were studied. The findings were correlated with clinical stage, particularly hepatic involvement, and histologic findings. Serum levels of other hepatic enzymes (SGOT, 5′N and γGT) were also measured. The usefulness of these studies for clinical staging was described, as well as speculation on the observed differences in Hodgkin's and non-Hodgkin's patients.
JensenH., SchiodtT.: Stromal response in breast carcinoma and fibroadenomatosis, estimated by the aid of the alkaline phosphatase activity.Acta Pathol. Microbiol. Scand., Section A,79: 321–329, 1971.
8.
KesslerT., RushR.L., LeonL., DeleaA., CupiolaR.: Automated 340 mm measurement of SGOT, SGPT and LHD.Clin. Chem.,16: 530–531, 1970.
9.
LumG., GabinoS.R.: Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone.Clin. Chem.,18: 358–362, 1972.
MorgensternS., KesslerG., AuerbachJ., FlorR.V., KleinB.: An automated p-nitrophenylphosphate serum alkaline phosphatase procedure for the autoanalyzer.Clin. Chem.,11: 876–888, 1965.
12.
NathansonL., FishmanW.H.: New observations on the Regan Isoenzyme of alkaline phosphatase in cancer patients.Cancer,27: 1388–1397, 1971.
13.
O'ConnellM.J., WiernikP.H., SklanskyB.D., GreeneW.H., AbtA.B., KirschnerR.H., RamseyH.E., MurphyW.L.: Staging laparotomy in Hodgkin's disease. Further evidence in support of its clinical utility.Am. J. Med.,57: 86–91, 1974.
14.
OehlertW., MusshoffK., WunschB., WillmannH., BeckK.: Unspezifische Mesenchymreaktionen und Parenchysmschaden der Leber bei Patienten mit morbus Hodgkin.Klin. Wochenschr.,48: 126–128, 1970.
15.
SnedecorG.W., CochranW. Gv.: Statistical Methods.Ames, Iowa, Iowa State University Press, p. 20, 1967.
16.
SzaszG.: A kinetic photometric method for serum y-glutamyl transpeptidase.Clin. Chem.,15: 124–136, 1969.
